CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
Levetiracetam +1 moredrug
Likely dose
Levetiracetam 2500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00566150
NCT00566150N/ACompleted
CompareCT.gov

Levetiracetam in the Management of Bipolar Depression

Yale University·interventional·Posted Dec 3, 2007·Updated Mar 31, 2020

In Brief

A clinical study evaluating Levetiracetam and Placebo for Bipolar Depression. Completed, enrolled 35 participants across 1 site.

Detailed Summary

A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Depression
CountriesUnited States
CollaboratorsStanley Medical Research Institute

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 3, 2007
Enrollment StartOct 1, 2005
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.6 years ago

Interventions

Levetiracetamdrug

Flexible dose up to 2500mg per day, for 6 weeks.

Placebodrug

Flexible dose up to 2500mg per day, for 6 weeks.